Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173741 | SCV000224889 | benign | not specified | 2015-05-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000544670 | SCV000650909 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000173741 | SCV000728450 | benign | not specified | 2017-09-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001573925 | SCV002048104 | likely benign | not provided | 2021-05-22 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000173741 | SCV002069856 | benign | not specified | 2017-08-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001573925 | SCV002545554 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BS1, BS2 |
Ambry Genetics | RCV002390419 | SCV002703360 | benign | Cardiovascular phenotype | 2019-03-12 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000173741 | SCV004241443 | likely benign | not specified | 2023-12-03 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001573925 | SCV001800485 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000173741 | SCV001925423 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000173741 | SCV001932206 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000173741 | SCV001952448 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001573925 | SCV001968659 | likely benign | not provided | no assertion criteria provided | clinical testing |